KNSA
#1065
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
60.9 4 USD
-0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.94%
Monthly Change
+17.76%
6 month change
+54.04%
Year Change
+53.71%
Previous Close
63.4 4
Open
60.9 4
Low
60.9 4
High
60.9 4
Volume
107
Financials
- Market Capitalization 7.62 B
- Employee 366
- Founded 2015
- CEO N/A
- Website www.kiniksa.com
- Headquarter N/A
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
52.91
Price to sales ratio
5.11
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.73 USD | -4.10% | +5.46% | +14.91% | +292.01% | 8.14 B USD | ||
| 1041 |  IMVT Immunovant, Inc. - Common Stock | 38.70 USD | -2.54% | -0.77% | +14.50% | +101.46% | 7.95 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +15.58% | -2.56% | 7.37 B USD | ||
| 1088 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 119.04 USD | -2.53% | -3.69% | +19.65% | +69.74% | 7.26 B USD |
Frequently asked questions about Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
What is the Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares stock price today?
The current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) is 60.94. Over the past 24 hours, the stock has changed by -3.94%. Follow the KNSA chart for real-time price dynamics.
What is the stock ticker of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trades under the ticker KNSA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares stock going up?
KNSA has changed by -3.73% over the last week, +17.76% over the last month, and +53.71% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares net income for the last quarter?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares reported net income of 22.59 M for the last quarter. The previous quarter showed 14.2 M, which means net income changed by +59.11%.
How many employees does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares have?
As of the latest available data, Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares has 366 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares EBITDA?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares EBITDA is 184.7 M, and its EBITDA margin is 86.2%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares stock?
You can buy Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares stock?
Investing in Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KNSA chart and related analysis on metatrader.com as part of your research.